Utah Medical Products Inc (NASDAQ: UTMD)

Utah Medical Products, Inc. designs manufactures and markets high quality cost effective medical devices that are distinguished by safety and improved patient outcomes. The company was formed as a Utah corporation in 1978 and completed its initial public offering in 1982. Over the decades it has built a broad product portfolio that serves labor and delivery neonatal intensive care and women's health markets. Utah Medical Products also supports outpatient clinics and physician offices with devices that meet specific clinical needs. The firm relies on internal product development strategic acquisitions and contract manufacturing to bring innovations to market. As of the end of 2025 Utah Medical Products operated manufacturing facilities in Utah and Ireland and maintained direct sales operations in Canada the United Kingdom France Ireland Australia and New Zealand.

Revenue is generated chiefly from the sale of medical devices including fetal monitoring accessories intrauterine pressure catheters vacuum assisted delivery systems neonatal respiratory hoods umbilical catheters enteral feeding sets electrosurgical generators and electrodes and disposable pressure transducers. The company also sells its Filshie Clip System and related applicators which represented 26 percent of total United States dollar denominated sales in 2025. In addition Utah Medical Products earns income by manufacturing components and finished devices on a subcontract basis for other medical device and non medical device firms. OEM sales and direct sales to clinical end users together constitute the core of the company's revenue streams. In 2025 outside the United States sales accounted for 41 percent of consolidated total revenue while domestic sales made up the remaining 59 percent.

Utah Medical Products occupies a specialized niche within the broader medical device industry concentrating on high reliability products for labor and delivery neonatal care and gynecology urology procedures. The company competes primarily on the basis of improved patient safety reliable device performance and strong brand recognition that has been built over decades of clinical use. It faces competition from large diversified medical device corporations and from low cost manufacturers located in Mexico East Europe India and China that offer contract manufacturing services. Utah Medical Products differentiates itself through its integrated engineering expertise in electronics software mechanical assembly plastics processing and materials science which enables rapid development of safe effective solutions. The firm benefits from long standing relationships with clinicians a direct sales force in key international markets and ISO 13485 certification that supports regulatory compliance and product quality. Utah Medical Products has also achieved certification under the Medical Device Single Audit Program for its facilities in Ireland the United Kingdom and Utah. These credentials help the company maintain access to global markets and reinforce its reputation for quality and reliability.

The company sells its devices directly to hospitals labor and delivery suites neonatal intensive care units and women's health centers in the United States and through its own subsidiaries in Canada the United Kingdom France Ireland Australia and New Zealand. Utah Medical Products also distributes products through independent medical device distributors in over a hundred countries with approximately two hundred of those distributors active in 2025. Among its OEM customers the most notable is PendoTECH which accounted for a significant portion of contract manufacturing sales in prior years. Additionally the company supplies components to a variety of medical and non medical device firms seeking to leverage its manufacturing capabilities. Utah Medical Products maintains long term relationships with group purchasing organizations and hospital administrators who influence purchasing decisions for its products.